Article

Carl Zeiss announces VISUCAMlite for increased retinal imaging

Washington, DC &#8212 The VISUCAMlite from Carl Zeiss Meditec Inc. offers practitioners the ability to capture digital images of the retina and posterior segment.

April 18 - Washington, DC - The VISUCAMlite from Carl Zeiss Meditec Inc. offers practitioners the ability to capture digital images of the retina and posterior segment.

VISUCAMlite is Carl Zeiss Meditec's latest digital imaging product, joining the FF 450plus fundus cameras to provide a full line of ophthalmic imaging devices.

The device offers the capability to capture and display photographs of the retina electronically. Color, red-free, and fluorescein angiography are the standard still-capture modes. VISUCAMlite also offers an innovative black-and-white video capture feature.

VISUCAMlite offers multiple ways to capture structural changes of the retina and posterior segment of the eye, providing a full-spectrum approach to diagnosis and documentation of retinal diseases and glaucoma. With advanced Zeiss optics, VISUCAMlite provides enhanced comfort for patients. The camera also provides maximum convenience for practices, as they are DICOM-conformant and capable of exporting images in a variety formats via a practice's network or the accompanying CD burner.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.